Drug Shortage Report for TEVA-IPRATROPIUM STERINEBS

Last updated on 2023-12-07 History
Report ID 198292
Drug Identification Number 02216221
Brand name TEVA-IPRATROPIUM STERINEBS
Common or Proper name TEVA-IPRATROPIUM STERINEBS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) IPRATROPIUM BROMIDE
Strength(s) 250MCG
Dosage form(s) SOLUTION
Route of administration INHALATION INHALATION
Packaging size 10x2M
ATC code R03BB
ATC description OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-07-11
Estimated end date 2024-02-20
Actual end date
Shortage status Actual shortage
Updated date 2023-12-07
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2023-12-07 French Compare
v12 2023-12-07 English Compare
v11 2023-11-03 French Compare
v10 2023-11-03 English Compare
v9 2023-10-12 French Compare
v8 2023-10-12 English Compare
v7 2023-07-27 French Compare
v6 2023-07-27 English Compare
v5 2023-07-18 French Compare
v4 2023-07-18 English Compare
v3 2023-07-12 English Compare
v2 2023-07-11 French Compare
v1 2023-07-11 English Compare

Showing 1 to 13 of 13